Michael T. Redman

Michael T. Redman

Amministratore Delegato presso
Theratome Bio, Inc.
71 anni
Health Technology
Commercial Services
Consumer Services

Profilo

Michael T.
Redman
was the founder of Opexa Pharmaceuticals, Inc. (2001) as Chief Executive Officer and Oncolix, Inc. (2006) as Chief Executive Officer & Director.
Mr. Redman is currently the Chief Executive Officer at Theratome Bio, Inc. Former positions include President, Chief Executive Officer, CFO & Director at Advanced Environmental Petroleum Producers, Inc., Chief Executive Officer at Botanix Pharmaceuticals Ltd., Director at Oncolix, Inc. (2006-2019), Principal at Wyeth LLC, Principal at Aronex Pharmaceuticals, Inc., Principal at Repros Therapeutics, Inc., Chief Operating Officer & Executive Vice President at Genprex, Inc. (2019-2021), and Principal at Biovail Pharmaceuticals LLC.
Education includes an undergraduate degree from the University of Missouri and an MBA from the University of Phoenix.

Posizioni attive di Michael T. Redman

SocietàPosizioneInizio
Amministratore Delegato -

Precedenti posizioni note di Michael T. Redman

SocietàPosizioneFine
GENPREX, INC. Direttore operativo 15/10/2021
ONCOLIX, INC. Amministratore Delegato -
Amministratore Delegato 01/01/2005
Corporate Officer/Principal -
Amministratore Delegato -
Vedi nel dettaglio l'esperienza di Michael T. Redman

Formazione di Michael T. Redman

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

8

Relazioni di 1° grado

14

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private14

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Consumer Services

Health Technology

Consumer Services

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

  1. Mercati
  2. Insiders
  3. Michael T. Redman